Neha Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Neha Singh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Tulika Seth
Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
2 shared publications - Rasika Gadkari
Department of Pathology, All India Institute of Medical Sciences, Nagpur, India
1 shared publication Ravneet Kaur
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
1 shared publication- Ravneet Kaur
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
1 shared publication - Richa Juneja
Department of Pathology, All India Institute of Medical Science, Nagpur, India
1 shared publication Sanjay K. Rai
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
1 shared publication
Latest Publications
- 30 September 2025
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 76 (4) , 1-6
Diagnostic Accuracy of an Erythrocyte Index-Based Protocol for Screening Beta Thalassemia Trait Among Antenatal Women in India
- 30 September 2025
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 76 (4) , 1-6
Diagnostic Accuracy of an Erythrocyte Index-Based Protocol for Screening Beta Thalassemia Trait Among Antenatal Women in India
- 5 April 2025
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 42 (2) , 449-455
Evaluation of Diagnostic Accuracy of Sickle SCAN™, and Gazelle™ for Screening Hemoglobin S in india
Sickle cell disease is a genetically inherited structural variation of hemoglobin most commonly encountered among people of African, Arabian and Indian origin. In this study, we aimed to evaluate the diagnostic accuracy of two point of care testing kits for Hemoglobin Sin laboratory settings. We conducted a prospective study among participants older than two years of age, excluding those who received blood transfusion in the last 3 months, recruited at a tertiary care hospital located in Maharashtra, India. The candidate test for the study were lateral flow immunoassay sickle SCAN™, and paper-based microchip electrophoresis device Gazelle™ (candidate tests) for screening hemoglobin S, while high performance liquid chromatography (HPLC) was the reference standard test. A consecutive sample of 470 patients were tested for both the candidate tests as well as HPLC. All positive tests on HPLC were also tested with sickling test before reporting as positive for hemoglobin S. We used HPLC followed by sickling test for diagnosis of hemoglobin SS and AS for the study. All positive as well as 10% of the negative results were randomly cross verified by an independent expert. The study participants consisted of 139 (29.5%) males and 331 females participants. The results were categorised as Hb SS (44) for homozygous sickle cell disease, Hb AS (64) for heterozygous sickle cell trait and non-S Hb (362) for any other hemoglobin phenotype detected (normal or any variant other than Hb S). Both the candidate tests were 100% sensitive for detecting Hb SS. The sensitivity for detecting Hb AS by Sickle Scan™ and Gazelle™ was 96.8% (89.1–99.6) and 98.4% (91.4–99.6) respectively. Both the candidate tests had high diagnostic accuracy for detecting Hb SS and Hb AS phenotypes. The intended used for the candidate tests is screening of Hb S among target population at point of care.
- 5 April 2025
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 42 (2) , 449-455
Evaluation of Diagnostic Accuracy of Sickle SCAN™, and Gazelle™ for Screening Hemoglobin S in india
Sickle cell disease is a genetically inherited structural variation of hemoglobin most commonly encountered among people of African, Arabian and Indian origin. In this study, we aimed to evaluate the diagnostic accuracy of two point of care testing kits for Hemoglobin Sin laboratory settings. We conducted a prospective study among participants older than two years of age, excluding those who received blood transfusion in the last 3 months, recruited at a tertiary care hospital located in Maharashtra, India. The candidate test for the study were lateral flow immunoassay sickle SCAN™, and paper-based microchip electrophoresis device Gazelle™ (candidate tests) for screening hemoglobin S, while high performance liquid chromatography (HPLC) was the reference standard test. A consecutive sample of 470 patients were tested for both the candidate tests as well as HPLC. All positive tests on HPLC were also tested with sickling test before reporting as positive for hemoglobin S. We used HPLC followed by sickling test for diagnosis of hemoglobin SS and AS for the study. All positive as well as 10% of the negative results were randomly cross verified by an independent expert. The study participants consisted of 139 (29.5%) males and 331 females participants. The results were categorised as Hb SS (44) for homozygous sickle cell disease, Hb AS (64) for heterozygous sickle cell trait and non-S Hb (362) for any other hemoglobin phenotype detected (normal or any variant other than Hb S). Both the candidate tests were 100% sensitive for detecting Hb SS. The sensitivity for detecting Hb AS by Sickle Scan™ and Gazelle™ was 96.8% (89.1–99.6) and 98.4% (91.4–99.6) respectively. Both the candidate tests had high diagnostic accuracy for detecting Hb SS and Hb AS phenotypes. The intended used for the candidate tests is screening of Hb S among target population at point of care.
- Open Access
- 1 August 2024
- Published by MDPI AG in Preprints.org
Strategy Recommendations for Population Screening of Sickle Cell Hemoglobin in Low Resource Setting
Hemoglobin S (Hb S) is genetically inherited variant of hemoglobin affecting around 300 000 infants are born annually. Facilitates for universal population testing of carrier state are available only in developed countries. The screening tests for Hb S have their respective limitations and the confirmatory tests are costly and require experts for conduct and interpretation. The use of two tests will enhance the overall diagnostic accuracy at the level of screening. We have considered two scenarios for population screening for SCD – community based in health camp mode / house to house survey and facility-based mode at health center. The combination of lateral flow immunoassay based POCT with sickling test can be used in absence of HPLC for population screening. However, for antenatal women portable microelectrophoresis based test is recommended as it flags the presence other hemoglobin variants along with Hb S.
- 1 August 2024
- Published by MDPI AG in Preprints.org
Open AccessStrategy Recommendations for Population Screening of Sickle Cell Hemoglobin in Low Resource Setting
Hemoglobin S (Hb S) is genetically inherited variant of hemoglobin affecting around 300 000 infants are born annually. Facilitates for universal population testing of carrier state are available only in developed countries. The screening tests for Hb S have their respective limitations and the confirmatory tests are costly and require experts for conduct and interpretation. The use of two tests will enhance the overall diagnostic accuracy at the level of screening. We have considered two scenarios for population screening for SCD – community based in health camp mode / house to house survey and facility-based mode at health center. The combination of lateral flow immunoassay based POCT with sickling test can be used in absence of HPLC for population screening. However, for antenatal women portable microelectrophoresis based test is recommended as it flags the presence other hemoglobin variants along with Hb S.
- 1 January 2020
- Published by Medknow in Journal of Marine Medical Society
- Vol. 22 (2) , 269-270
Nutritional prehabilitation in COVID-19 - “Food for Thought”
Journal of Marine Medical Society, India
- 1 January 2020
- Published by Medknow in Journal of Marine Medical Society
- Vol. 22 (2) , 269-270
Nutritional prehabilitation in COVID-19 - “Food for Thought”
Journal of Marine Medical Society, India
- 1 January 2018
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 74 (1) , 93-94
Indian Diabetes Risk Score: Use beyond population screening for diabetes
- 1 January 2018
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 74 (1) , 93-94
Indian Diabetes Risk Score: Use beyond population screening for diabetes